N-arylpyrimidinamine (NAPA) compounds are broadly acting inhibitors of human cytomegalovirus infection and spread.

Autor: Atanasoff KE; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Ophir SI; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Parsons AJ; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Paredes Casado J; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Lurain NS; Department of Immunology-Microbiology, Rush University, Chicago, IL, USA., Bowlin TL; Microbiotix, Inc., Worcester, MA, 01605, USA., Opperman TJ; Microbiotix, Inc., Worcester, MA, 01605, USA., Tortorella D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. Electronic address: domenico.tortorella@mssm.edu.

Publikováno v: Antiviral research [Antiviral Res] 2024 Nov 27; Vol. 233, pp. 106044. Date of Electronic Publication: 2024 Nov 27.